TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 117 filers reported holding TG THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
| M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
| Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
| Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
| Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
| 683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
| Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
| Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
| Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
| Artal Group S.A. | 511,389 | $7,691 | 0.46% |